Lecap Asset Management Ltd. acquired a new position in shares of Molina Healthcare, Inc (NYSE:MOH – Free Report) in the second quarter, Holdings Channel reports. The fund acquired 1,093 shares of the company’s stock, valued at approximately $326,000.
Other institutional investors have also made changes to their positions in the company. ASR Vermogensbeheer N.V. increased its stake in Molina Healthcare by 57.7% in the second quarter. ASR Vermogensbeheer N.V. now owns 2,087 shares of the company’s stock valued at $622,000 after acquiring an additional 764 shares during the period. Robeco Institutional Asset Management B.V. boosted its holdings in Molina Healthcare by 426.5% during the second quarter. Robeco Institutional Asset Management B.V. now owns 17,094 shares of the company’s stock valued at $5,092,000 after purchasing an additional 13,847 shares in the last quarter. Greenleaf Trust grew its stake in shares of Molina Healthcare by 7.6% in the 2nd quarter. Greenleaf Trust now owns 1,436 shares of the company’s stock valued at $428,000 after purchasing an additional 101 shares during the period. V Square Quantitative Management LLC grew its stake in shares of Molina Healthcare by 7.5% in the 2nd quarter. V Square Quantitative Management LLC now owns 1,758 shares of the company’s stock valued at $524,000 after purchasing an additional 123 shares during the period. Finally, Tempus Wealth Planning LLC raised its holdings in shares of Molina Healthcare by 49.8% in the 2nd quarter. Tempus Wealth Planning LLC now owns 1,875 shares of the company’s stock worth $559,000 after buying an additional 623 shares in the last quarter. 98.50% of the stock is currently owned by institutional investors and hedge funds.
Molina Healthcare Stock Performance
MOH stock opened at $202.59 on Friday. The company has a 50 day moving average price of $174.21 and a 200 day moving average price of $253.21. Molina Healthcare, Inc has a fifty-two week low of $151.95 and a fifty-two week high of $359.97. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.66 and a quick ratio of 1.66. The stock has a market capitalization of $10.98 billion, a PE ratio of 9.98 and a beta of 0.55.
Insider Transactions at Molina Healthcare
In other news, COO James Woys acquired 10,000 shares of the stock in a transaction that occurred on Monday, August 4th. The stock was purchased at an average cost of $155.94 per share, for a total transaction of $1,559,400.00. Following the completion of the transaction, the chief operating officer directly owned 74,331 shares in the company, valued at $11,591,176.14. This trade represents a 15.54% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Ronna Romney sold 700 shares of the business’s stock in a transaction dated Wednesday, August 6th. The stock was sold at an average price of $153.74, for a total value of $107,618.00. Following the sale, the director directly owned 17,131 shares of the company’s stock, valued at $2,633,719.94. This represents a 3.93% decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.10% of the stock is owned by company insiders.
Wall Street Analyst Weigh In
MOH has been the topic of several recent analyst reports. Wall Street Zen lowered Molina Healthcare from a “buy” rating to a “hold” rating in a research note on Sunday, June 29th. Sanford C. Bernstein reduced their target price on shares of Molina Healthcare from $284.00 to $220.00 and set an “outperform” rating on the stock in a research note on Friday, September 5th. Wells Fargo & Company lowered their target price on shares of Molina Healthcare from $216.00 to $198.00 and set an “overweight” rating on the stock in a report on Friday, August 15th. Robert W. Baird reduced their price target on shares of Molina Healthcare from $373.00 to $179.00 and set a “neutral” rating on the stock in a research report on Friday, July 25th. Finally, Truist Financial reaffirmed a “hold” rating and set a $180.00 price objective (down from $335.00) on shares of Molina Healthcare in a research note on Friday, July 25th. Three equities research analysts have rated the stock with a Buy rating, ten have issued a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, the stock has an average rating of “Hold” and a consensus target price of $225.18.
Get Our Latest Stock Report on Molina Healthcare
About Molina Healthcare
Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.
Further Reading
- Five stocks we like better than Molina Healthcare
- How to Use the MarketBeat Stock Screener
- After Trump Deal, Can Meta Stock Withstand TikTok’s Onslaught?
- What is a penny stock? A comprehensive guide
- Alphabet: After Its Best Quarter in Decades, Is It Time to Buy?
- Why Are Stock Sectors Important to Successful Investing?
- Forget Airlines—These Trucking Stocks Are Shifting Into High Gear
Want to see what other hedge funds are holding MOH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Molina Healthcare, Inc (NYSE:MOH – Free Report).
Receive News & Ratings for Molina Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.